AstraZeneca’s Evusheld Authorized for Covid Prevention: FDA

AstraZeneca’s Evusheld received emergency use authorization from the U.S. FDA.

• The product was authorized for emergency use as pre-exposure prophylaxis for prevention of Covid-19 in some adults and pediatric individuals, the FDA said

NOTE

• EU Drug Regulator Starts Rolling Review of Astra’s Evusheld
• AstraZeneca Plc rose 0.47% to GBP83 as of 11:14 a.m. New York time
  • The average 12-month price target of 101 pounds is 23% above the current price
  • 28 buys, 4 holds, 2 sells

To contact the reporter on this story:
Greg Chang in San Francisco at gchang1@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli ...